-
公开(公告)号:US20230095383A1
公开(公告)日:2023-03-30
申请号:US17911241
申请日:2020-03-17
申请人: DST Pharma, Inc.
发明人: Lu Wang
IPC分类号: A61K36/70 , A61K36/28 , A61K36/482 , A61K36/536 , A61K36/634 , A61K36/31 , A61K36/282 , A61K36/36 , A61K36/076 , A61K31/352 , A61K31/7048 , A61K31/58 , A61P31/14
摘要: Nutraceutical compositions and methods of their use in treating Caliciviridae family viruses are provided. The viruses can be norovirus or sapovirus. An exemplary nutraceutical composition includes Fagopyrum dibotyo extract. Another nutraceutical composition for treating viral gastroenteritis includes 5, 7, 3′, 4′-tetrahydroxyflavan-3-ol C4-C8 dimers, quercetin, rutin, or a combination thereof. The nutraceutical compositions inhibit or reduce entry of Caliciviridae family viruses into intestinal epithelial cells of the subject.
-
公开(公告)号:US20230043437A1
公开(公告)日:2023-02-09
申请号:US17790646
申请日:2021-01-05
申请人: NANTONG UNIVERSITY
发明人: Xiaosong GU , Chunkang TANG , Fei DING , Xiaoming YANG , Qiong CHENG , Hualin SUN , Lai XU
IPC分类号: A61K36/481 , A61K36/64 , A61K36/21 , A61K36/725 , A61K36/815 , A61K36/232 , A61K36/286 , A61K36/076 , A61K36/284
摘要: Disclosed are a compound preparation for neuranagenesis, and a preparation method therefor and the use thereof. The compound preparation for neuranagenesis comprises the raw medicinal materials in parts by weight: 10-20 parts of raw Astragali radix, 10-20 parts of Rehmaimiae Radix praeparata, 10-20 parts of Actyranthes bidentata, 6-15 parts of Jujubae fructus, 6-15 parts of Lycii fructus, 6-15 parts of parched Ziziphi spinosae semen, 6-12 parts of Angelicae smensis radix, 3-9 parts of Carthami flos, 6-15 parts of Poria, 6-15 parts of parched Atractylodis macrocephalae rhizoma and 10-20 parts of Zaocys. The compound preparation can be used for preparing drugs to treat nerve damage diseases, and can be prepared into oral liquids, granules, dissolved granules and tablets.
-
公开(公告)号:US11524044B2
公开(公告)日:2022-12-13
申请号:US17151923
申请日:2021-01-19
发明人: Lizhu Lin , Hongmei Tang , Jianfeng Gan , Detang Li , Lingling Sun
IPC分类号: A61K36/898 , A61P35/00 , A61K9/16 , A61K36/076 , A61K36/18 , A61K36/28 , A61K36/284 , A61K36/344 , A61K36/484 , A61K36/539 , A61K36/638 , A61K36/736
摘要: This invention provides a strengthening and tumor eliminating traditional Chinese medicine composition, its preparation method and application, which specifically relate to the technical field of the treatment of intermediate and advanced stage and postoperative malignant tumor, wherein the strengthening and tumor eliminating traditional Chinese medicine composition comprises: 8-30 parts of Radix codonopsis, 5-30 parts of Rhizoma atractylodis Macrocephalae, 5-30 parts of Poria cocos, 5-30 parts of Pseudobulb of Appendiculate cremastra, 5-30 parts of Scutellaria barbata, 5-30 parts of Sarcandra glabra, 3-30 parts of peach kernel, 2-30 parts of Ligustrum lucidum, 5-30 parts of Eclipta and 1-20 parts of licorice. This invention also provides a preparation method of the described strengthening and tumor eliminating traditional Chinese medicine composition.
-
公开(公告)号:US11478523B2
公开(公告)日:2022-10-25
申请号:US16811849
申请日:2020-03-06
申请人: Hyong Jun Kim
发明人: Hyong Jun Kim , Sung Sook Kim
IPC分类号: A61K36/804 , A61K36/232 , A61K36/815 , A61K36/65 , A61K36/8945 , A61K36/284 , A61K36/8964 , A61K36/756 , A61K36/484 , A61K36/076 , A23L33/105
摘要: The present disclosure relates to an oriental medicine composition effective for thyroid hormone level normalization, and more particularly, to an oriental medicine composition for treating thyroid diseases, such as hypothyroidism or hyperthyroidism.
-
公开(公告)号:US20220280588A1
公开(公告)日:2022-09-08
申请号:US17632865
申请日:2019-08-06
申请人: Mingchun XIAO
发明人: Mingchun XIAO
IPC分类号: A61K36/8988 , A61K36/284 , A61K36/076 , A61K36/752 , A61K36/484 , A61K36/8888 , A61K36/74 , A61K36/236 , A61K36/264 , A61K36/59 , A61K36/714 , A23L33/00 , A23L33/105 , A23K10/30
摘要: Use of addition and subtraction of the Banxia Baizhu Tianma Decoction in preparation of medicines or health products for treating strokes caused by deep fungal infections. The present invention relates to the field of medical and health care, and specifically relates to use of chemical ingredients, i.e. alkaloids and volatile oils contained in plant raw materials such as Gastrodia elata, Pinellia ternata, Atractylodes macrocephala, Poria cocos, fresh orange peel and Liquorice to prepare drugs or health products for treating strokes caused by deep fungal infections.
-
公开(公告)号:US20220054574A1
公开(公告)日:2022-02-24
申请号:US17409288
申请日:2021-08-23
发明人: Be XIE , Xuefeng REN
IPC分类号: A61K36/79 , A61K36/076 , A61K36/75 , A61K36/736 , A61K36/484 , A61K36/34 , A61K36/539
摘要: The present application relates to methods of preventing, treating or managing a respiratory disease and/or a viral infection (e.g., an influenza virus infection and COVID-19) using a pharmaceutical composition produced from one or more preparations of plant parts. Provided herein are the pharmaceutical compositions produced from the one or more preparations. Also provided herein are methods of producing the pharmaceutical composition from the one or more preparations.
-
公开(公告)号:US20220054573A1
公开(公告)日:2022-02-24
申请号:US17409313
申请日:2021-08-23
发明人: Be XIE , Xuefeng REN
IPC分类号: A61K36/736 , A61K36/076 , A61K36/484 , A61K45/06 , A61K9/00 , A61P31/16
摘要: The present application relates to methods of preventing, treating or managing chronic obstructive pulmonary disease (COPD) and/or other obstructive lung diseases using a pharmaceutical composition produced from one or more preparations of plant parts. Provided herein are the pharmaceutical compositions produced from the preparations. Also provided herein are methods of producing the pharmaceutical compositions.
-
公开(公告)号:US20220054569A1
公开(公告)日:2022-02-24
申请号:US16995903
申请日:2020-08-18
申请人: Da-Tong JU
发明人: Hsuan-Ching TSENG , Da-Tong JU , Sung-Sen YANG , Wei-Te CHENG , Chen-Yu LEE , Yan-Chih LIAO , Juei-Yang LO , Luan-Yao CHIEN
IPC分类号: A61K36/282 , A61K36/808 , A61K36/40 , A61K36/284 , A61K36/756 , A61K36/484 , A61K36/64 , A61K36/8945 , A61K36/076 , A61K36/65 , A61K36/81 , A61K36/31 , A61K36/21
摘要: A method for treating a side effect caused by bacillus Calmette-Guérin (BCG) perfusion therapy for bladder cancer includes: administering a Chinese medicine composition to a subject in need thereof; wherein, the Chinese medicine composition is an extract of a first mixture comprising Rhizoma anemarrhenae, Cortex phellodendri, Glycyrrhiza uralensis, Rehmanniae Radix, Fructus corni, Rhizoma dioscoreae, Poria, Moutan cortex, Rhizoma Alismatis, Radix achyranthis bidentatae, and Atractylodes lancea.
-
公开(公告)号:US11235018B2
公开(公告)日:2022-02-01
申请号:US16249501
申请日:2019-01-16
申请人: OKCHUNDANG CO., LTD.
发明人: Sae Kwang Ku , Seong Min Ku , Tae Hun Ku , Chui Jong Jung , Gyung Yun Beik , Jin Gi Shin , Sang Soo Lee , Jeong Gyun Seo , Chil Surk Yoon , Xian Li
IPC分类号: A61K36/64 , A61K36/258 , A61K36/342 , A61K36/076 , A61K31/5377 , A61P35/00 , A23L33/105 , A61K35/644
摘要: The present invention provides a pharmaceutical composition for preventing or treating cancer, a food composition for enhancing immune functions, and a pharmaceutical composition for preventing or treating cachexia. The composition of the present invention provides effects of further inhibiting the growth of tumors, increasing immunological activity, and suppressing cachexia caused by tumors. In addition, the composition of the present invention can obtain a synergistic effect when co-administered with an existing anticancer drug.
-
公开(公告)号:US20210308203A1
公开(公告)日:2021-10-07
申请号:US17350751
申请日:2021-06-17
申请人: Byung-Jun Park
发明人: Byung-Jun Park
IPC分类号: A61K36/65 , A61K36/74 , A61K36/284 , A61K36/076 , A61K36/234 , A61P25/16 , A61K36/54 , A61K36/258 , A61K36/484 , A61K36/67 , A61K36/48 , A61K36/725
摘要: Provided herein are compositions for treating a disorder or a disease associated with or characterized by neuro-inflammation, neuro-apoptosis, or neuro-oxidative damage in a subject, pharmaceutical compositions comprising the compositions and pharmaceutically acceptable excipients, and nutraceutical compositions comprising the compositions and nutraceutically acceptable excipients. Provided also herein are methods of treating a disorder or a disease associated with or characterized by neuro-inflammation, neuro-apoptosis, or neuro-oxidative damage in a subject in need thereof, methods of reducing, alleviating, or delaying a sign or a symptom of a disorder characterized by neuro-inflammation, neuro-apoptosis, or neuro-oxidative damage in a subject in need thereof, and methods of regulating inflammation, antioxidant enzymes, and apoptosis in a subject having a disorder or a disease associated with or characterized by neuro-inflammation, neuro-apoptosis, or neuro-oxidative damage.
-
-
-
-
-
-
-
-
-